Gene · 4173
Papers2,283
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,283
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification and evaluation of plasma exosome RNA biomarkers for non-invasive diagnosis of hepatocellular carcinoma using RNA-seq. | BMC Cancer | 2024 | 39696145 | PubTator, text mining | PubMed |
| Integrated network pharmacology and transcriptomic approach reveal the role of equol in reducing colorectal cancer via regulating multiple cell cycle genes in HCT116 cells. | Int J Biol Macromol | 2024 | 39461627 | PubTator, text mining | PubMed |
| Co-delivery of siRNA and cisplatin via electrospun Nanofibrous membranes for synergistic treatment of malignant melanoma. | Heliyon | 2024 | 39290263 | PubTator, text mining | PubMed |
| MCM4 potentiates evasion of hepatocellular carcinoma from sorafenib-induced ferroptosis through Nrf2 signaling pathway. | Int Immunopharmacol | 2024 | 39276458 | PubTator, text mining | PubMed |
| Replication Stress in Activated Human NK Cells Induces Sensitivity to Apoptosis. | J Immunol | 2024 | 38809096 | PubTator, text mining | PubMed |
| Proteo-genomic characterization of cirrhosis-associated liver cancers reveals potential subtypes and therapeutic targets. | Clin Transl Oncol | 2024 | 38806996 | PubTator, text mining | PubMed |
| Partial Alleviation of Homologous Superinfection Exclusion of SeMNPV Latently Infected Cells by G1 Phase Infection and G2/M Phase Arrest. | Viruses | 2024 | 38793618 | PubTator, text mining | PubMed |
| IsoVis - a webserver for visualization and annotation of alternative RNA isoforms. | Nucleic Acids Res | 2024 | 38709877 | PubTator, text mining | PubMed |
| Elucidation of clinical implications Arising from circadian rhythm and insights into the tumor immune landscape in breast cancer. | Heliyon | 2024 | 38500978 | PubTator, text mining | PubMed |
| Multi-omics pan-cancer analyses identify MCM4 as a promising prognostic and diagnostic biomarker. | Sci Rep | 2024 | 38499612 | PubTator, text mining | PubMed |
| A critical threshold of MCM10 is required to maintain genome stability during differentiation of induced pluripotent stem cells into natural killer cells. | Open Biol | 2024 | 38262603 | PubTator, text mining | PubMed |
| Exploring Biomarkers in Breast Cancer: Hallmarks of Diagnosis, Treatment, and Follow-Up in Clinical Practice. | Medicina (Kaunas) | 2024 | 38256428 | PubTator, text mining | PubMed |
| Heterogeneous Expression Patterns of the Minichromosome Maintenance Complex Members in Retinoblastoma Unveil Its Clinical Significance. | Invest Ophthalmol Vis Sci | 2024 | 38231525 | PubTator, text mining | PubMed |
| Unraveling the dynamic mechanisms of natural killer cells in viral infections: insights and implications. | Virol J | 2024 | 38216935 | PubTator, text mining | PubMed |
| Identification of MCM4 and PRKDC as new regulators of osteosarcoma cell dormancy based on 3D cell cultures. | Biochim Biophys Acta Mol Cell Res | 2024 | 38216092 | PubTator, text mining | PubMed |
| Transcriptome analysis of adenomyosis eutopic endometrium reveals molecular mechanisms involved in adenomyosis-related implantation failure and pregnancy disorders. | Reprod Biol Endocrinol | 2024 | 38195505 | PubTator, text mining | PubMed |
| Mechanism-centric regulatory network identifies NME2 and MYC programs as markers of Enzalutamide resistance in CRPC. | Nat Commun | 2024 | 38191557 | PubTator, text mining | PubMed |
| The oncogenic role and regulatory mechanism of PGK1 in human non-small cell lung cancer. | Biol Direct | 2024 | 38163864 | PubTator, text mining | PubMed |
| Human retinal organoids with an OPA1 mutation are defective in retinal ganglion cell differentiation and function. | Stem Cell Reports | 2024 | 38101398 | PubTator, text mining | PubMed |
| PPM1D activity promotes the replication stress caused by cyclin E1 overexpression. | Mol Oncol | 2024 | 37067201 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4173/papers?page=4